Ikarian Capital, LLC Nuvation Bio Inc. Transaction History
Ikarian Capital, LLC
- $573 Million
- Q3 2024
A detailed history of Ikarian Capital, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 83,282 shares of NUVB stock, worth $217,366. This represents 0.03% of its overall portfolio holdings.
Number of Shares
83,282
Previous 358,282
76.76%
Holding current value
$217,366
Previous $1.05 Million
81.74%
% of portfolio
0.03%
Previous 0.42%
Shares
9 transactions
Others Institutions Holding NUVB
# of Institutions
159Shares Held
157MCall Options Held
3.2KPut Options Held
98.7K-
Decheng Capital LLC Menlo Park, CA26MShares$67.7 Million14.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA19.2MShares$50.1 Million1.92% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$42.4 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$34.1 Million44.61% of portfolio
-
Octagon Capital Advisors LP New York, NY12.2MShares$31.8 Million6.76% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $567M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...